Bir sonraki

Otomatik oynatma

Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas

14 Görünümler • 07/18/23
Pay
gömmek
administrator
administrator
Aboneler
0

Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma